INSULIN Act of 2026 aims to reduce insulin prices and protect patients from high costs.
The INSULIN Act of 2026 seeks to reduce the price of insulin and protect patients from high costs by mandating that group health plans and health insurance issuers cover selected insulin products without applying deductibles or imposing cost-sharing above $35 per 30-day supply. The Act also requires the establishment of an insulin resource center and hotline to assist uninsured individuals, and mandates a study on the characteristics of uninsured insulin users.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.